Latest News & Features
Europe
London-based imaging company Imanova develops ‘imaging biomarkers’ to support the business of drug discovery, and takes a novel approach to protecting its innovations. LSIPR spoke to chief executive Kevin Cox about the company’s strategy. 30 May 2014
Americas
The new examination guidelines do not carry the weight of law, and it is not likely that their more extreme aspects will withstand judicial scrutiny, but practitioners need to keep tabs on court decisions, says Courtenay C. Brinckerhoff. 30 May 2014
Big Pharma
A pharmaceutical company in Turkey has run into trouble after attempting to register the Turkish word for ‘pharmacist’ as a trademark. 29 May 2014
Big Pharma
Teva has successfully defended a patent for its multiple sclerosis drug Copaxone (glatiramer acetate) in Europe. 28 May 2014
Biotechnology
Justice Colin Birss has refused Roche’s biotechnology subsidiary Genentech the permission to appeal against an English High Court decision in which two patents covering its blockbuster breast cancer drug, Herceptin (trastuzumab), were revoked. 27 May 2014
Americas
US-based drug company Acura and Novartis’s generic arm Sandoz have settled their patent infringement dispute related to an abuse-deterrent formulation of the painkiller Aversion (oxycodone). 23 May 2014
Europe
Generics (UK) Limited, the UK arm of Mylan, has succeeded in invalidating a patent held by Hungarian pharmaceutical company Richter Gedeon at the English High Court. 22 May 2014
Americas
Medical device rivals Medtronic and Edwards Lifesciences have agreed to settle all patent litigation, including cases related to transcatheter heart valves. 21 May 2014
Generics
The United Nations Development Programme has released a guidebook for low- to middle- income countries on how to increase access to essential health technologies and HIV treatments by using competition law and policy. 20 May 2014
Americas
A US district court has dismissed Teva’s case against the FDA aimed at stopping the administration from approving generic versions of its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate). 19 May 2014